Snapshot from May 30, 2026 at 07:00 UTC. For live data and tracking: View Live

Nektar Therapeutics & Philip Kim

1 shared events · Importance 3 · Last updated May 05, 2026

Importance
3
Shared Events
1
Actions
0
Sentiment
-56.666666666666664
Live sentiment trends, interaction importance charts, and action volume tracking available on the NewsDesk Dashboard
63
Business
Nektar Therapeutics: Nektar Therapeutics is the defendant in a class action lawsuit alleging misleading statements regarding its REZOLVE-AA trial, which led to a significant drop in its stock price.
Philip Kim: Philip Kim, an attorney at Rosen Law Firm, is a contact person for investors interested in joining the class action lawsuit against Nektar Therapeutics.
Apr 07, 2026 · 30 articles
NEWSDESK
Explore this relationship live

Track how Nektar Therapeutics and Philip Kim interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.